晚期慢性静脉疾病与非血栓性髂静脉病变患者的支架通畅率
回顾性分析2013年1月至2014年12月210例因非血栓性髂静脉病变行髂静脉支架置入的C3-C5级患者,共268例手术。平均随访437天,6个月、1年、2年支架一期通畅率分别为98.7%、98.3%、97.9%,支架内血栓形成4例(1.5%)。作者结论为中期通畅率优异(98.5%)。
要点
- 268例髂静脉支架手术中,6个月、1年、2年一期通畅率分别为98.7%、98.3%、97.9%。
- 支架内血栓形成4例,占268例的1.5%。
- 作者结论认为晚期慢性静脉疾病患者髂静脉支架中期通畅率优异(98.5%)。
核心结论
- 作者结论认为,晚期慢性静脉疾病患者置入髂静脉支架的中期通畅率优异(98.5%)。
- 借助血管内超声(IVUS),作者明确记录了髂静脉节段的平均面积以及狭窄最常见的位置。
研究设计与样本
- 回顾性分析2013年1月至2014年12月间210例接受髂总或髂外静脉球囊扩张及支架置入术的患者,共268例手术。
- 仅纳入临床-病因-解剖-病理生理(CEAP)分级为C3、C4或C5的患者,排除初始静脉造影或IVUS显示活动性溃疡或血栓后病变征象者。
- 在术者决定下行超声引导下股静脉或股总静脉穿刺,随后行上行静脉造影;初始上行静脉造影未明确狭窄者使用IVUS。
- 术后嘱患者每日服用氯吡格雷75 mg,随访时用腹部静脉双功超声评估支架通畅性,随访时长和通畅率基于最近一次双功超声。
主要发现
- 210例患者共行268例手术,58例需双侧下肢支架置入,173例(64.6%)手术在女性中实施,平均年龄72 ± 15岁。
- 268例手术中144例(53.7%)在左下肢实施,CEAP分级C3、C4、C5分别占58%、30%、12%。
- 平均随访437天(中位数499天,范围1-1060天),随访超过6个月、1年、2年的比例分别为71.3%、57.1%、28.7%。
- 268例肢体中4例(1.5%)发生支架内血栓形成,6个月、1年、2年一期支架通畅率分别为98.7%、98.3%、97.9%。
临床怎么用
- 术后嘱患者每日服用氯吡格雷75 mg,随访时以腹部静脉双功超声评估支架通畅性。
- 初始上行静脉造影未明确狭窄时使用IVUS辅助评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Midterm patency results of iliac vein stents placed for nonthrombotic iliac vein lesions (NIVLs) are not widely known. Previously published studies involving large series of patients with iliac vein stent placement have failed to clearly demonstrate the outcomes for patients with NIVLs and advanced disease. To further study this issue, we reviewed our series of 268 iliac vein stents placed for NIVLs. METHODS: Retrospective analysis was performed of 210 patients who underwent common or external iliac vein angioplasty and stent placement procedures between January 2013 and December 2014. Only patients with Clinical, Etiology, Anatomy, and Pathophysiology classification scores of C3, C4, or C5 were included. Patients were excluded if they had either active ulcer disease or signs of post-thrombotic lesions at initial venography or intravascular ultrasound (IVUS). Ultrasound-guided puncture was performed of the femoral or common femoral vein at the discretion of the surgeon. This was followed by ascending venography. IVUS was used in cases in which a definite stenosis was not appreciated on initial ascending venography. Balloon angioplasty and stents were applied across lesions. After the procedure, patients were instructed to use clopidogrel 75 mg daily. Patency of the stents was assessed during a follow-up visit with abdominal venous duplex ultrasound scans. The length of the patients' follow-up and stent patency rates were based on the last previous duplex ultrasound scan available. RESULTS: A total of 268 procedures were performed in 210 patients. Bilateral lower extremity stent placements were required in 58 patients; 173 (64.6%) procedures were performed in women. The average age of our patients was 72 ± 15 (standard deviation) years. Of the 268 procedures, 144 (53.7%) were performed in the left lower extremity. The Clinical, Etiology, Anatomy, and Pathophysiology classification of lower extremity venous disease was 58%, 30%, and 12% for C3, C4, and C5, respectively. Our average follow-up period was 437 days (median, 499 days; range, 1-1060 days). Patients were observed for >6 months, 1 year, and 2 years in 71.3%, 57.1%, and 28.7% of cases, respectively. During this period, 4 of the 268 (1.5%) limbs experienced in-stent thrombosis. Primary stent patency of 98.7%, 98.3%, and 97.9% was noted at 6 months, 1 year, and 2 years of follow-up, respectively. CONCLUSIONS: Our midterm patency rates for iliac vein stents placed in patients with advanced chronic venous disease demonstrated excellent (98.5%) results. Furthermore, with IVUS assistance, we have clearly documented the average area of iliac venous segments as well as the most common locations of the stenoses.
引用
- Rizvi SA, Ascher E, Hingorani A, et al. Stent patency in patients with advanced chronic venous disease and nonthrombotic iliac vein lesions. J Vasc Surg Venous Lymphat Disord. 2018. PMID: 29909853. doi:10.1016/j.jvsv.2018.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。